InvestorsHub Logo
Followers 864
Posts 27574
Boards Moderated 1
Alias Born 11/05/2010

Re: None

Monday, 01/28/2013 8:02:24 AM

Monday, January 28, 2013 8:02:24 AM

Post# of 11554
BTHE. Boston Therapeutics Announces Clinical Study Final Results Indicate That SUGARDOWN(R) Reduced the Post-Meal Elevation of Blood Glucose by up to 61% in Healthy Volunteers
No Severe Adverse Effects Observed
http://finance.yahoo.com/news/boston-therapeutics-announces-clinical-study-123000098.html

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.